As Election Day 2018 nears, President Trump and Congress pulled off a rare feat, rallying around the signing of bipartisan legislation that will attempt to combat opioid use disorder, which took more than 42,000 lives in 2016.
As Election Day 2018 nears, President Trump and Congress pulled off a rare feat, rallying around the signing of bipartisan legislation that will attempt to combat opioid use disorder, which took more than 42,000 lives in 2016.
According to the White House, the law—actually a package of dozens of bills stitched together in a series of marathon hearings earlier this year—seeks to reduce demand, cut the flow of illegal drugs into the country, and expand evidence-based treatment.
At the bill signing ceremony, representatives from 21 companies or organizations were in attendance, having decided to support the effort in various ways.
Blue Cross Blue Shield Association (BCBS), for instance, reaffirmed its intent to launch Blue Distinction Centers for Substance Use Treatment and Recovery. BCBS will also establish a free national hotline to help people, even those not covered by the company, locate treatment centers. But it will be 2 years before either program is up and running.
For those who work in the field, there are questions about how this will all work and what the impact will be.
“Frankly, the things that are helpful about all of this is related to a broader discussion and decreasing stigma,” said Arwen Podesta, MD, ABPN, FASAM, ABIHM, a psychiatrist in Louisiana who is presenting about medication assisted treatment at the Psych Congress 2018 annual meeting this weekend. “But addiction is addiction, and even though this opioid thing is out of control, it is certainly not the only problem. There are genetic and biological underpinnings of addiction for some people, and traumatic underpinnings for others. And some with both. So removing the drug is never the only thing—we have to treat the biology and the environment, too.”
In an email to The American Journal of Managed Care®, Podesta said implementation will be key. “How exactly will each state use the money? Will they actually improve access to quality treatment or just low level treatment? Are we improving quality of life or just preventing overdoses? There needs to be much more education on the underlying reasons people get addicted in the first place, and on early interventions and quality treatment types.”
The law does seek to increase the quality of treatment centers; it also makes changes to Medicare and Medicaid as they relate to substance use disorder. And Thursday, America’s Health Insurance Plans released a report about low-quality, fraudulent “sober homes,” which the law also targets.
Also this week, the American Society of Addiction Medicine launched an educational program for primary care providers seeking additional training on treating addiction. Increasing the number of primary care clinicians able to offer medication-assisted treatment is another goal of the law.
Still, there is the question of funding—the law includes about $7 billion over 2 years to fight the problem, and the money was already authorized. Some health experts have said that much more is needed, and last spring, Senator Elizabeth Warren, D-Massachusetts, and Representative Elijah Cummings, D-Maryland, called for $100 billion a year for 10 years to be spent on the problem.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More